Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Sanara MedTech Inc. (SMTI : NSDQ)

• Company Description    Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas. Number of Employees: 141

• Price / Volume Information    Yesterday's Closing Price: $30.67 Daily Weekly Monthly 20 Day Moving Average: 48,226 shares Shares Outstanding: 8.89 (millions) Market Capitalization: $272.59 (millions) Beta: 1.30 52 Week High: $39.08 52 Week Low: $25.86 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.90% 2.90% 12 Week 4.21% -12.34% Year To Date -7.62% -13.49%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1200 Summit Avenue Suite 414 - Fort Worth,TX 76102 USA ph: 817-529-2300 fax: - ir@sanaramedtech.com http://www.sanaramedtech.com

• General Corporate Information    Officers Ronald T. Nixon - Chairman and Chief Executive Officer Elizabeth B. Taylor - Chief Financial Officer Michael D. McNeil - Chief Accounting Officer and Chief Administrative Robert DeSutter - Director Roszell Mack - Director Peer Information Sanara MedTech Inc. (BJCT) Sanara MedTech Inc. (CADMQ) Sanara MedTech Inc. (APNO) Sanara MedTech Inc. (UPDC) Sanara MedTech Inc. (IMTIQ) Sanara MedTech Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 79957L100 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/11/25 Share - Related Items Shares Outstanding: 8.89 Most Recent Split Date: 5.00 (0.01:1) Beta: 1.30 Market Capitalization: $272.59 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.32 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.56 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 7.43 Price/Cash Flow: - Price / Sales: 2.98 EPS Growth vs. Year Ago Period: -95.24% vs. Previous Quarter: -127.78% Sales Growth vs. Year Ago Period: 26.42% vs. Previous Quarter: -10.91% ROE 06/30/25 - - 03/31/25 - -29.22 12/31/24 - -23.75 ROA 06/30/25 - - 03/31/25 - -13.20 12/31/24 - -12.05 Current Ratio 06/30/25 - - 03/31/25 - 2.77 12/31/24 - 2.18 Quick Ratio 06/30/25 - - 03/31/25 - 2.54 12/31/24 - 2.00 Operating Margin 06/30/25 - - 03/31/25 - -12.48 12/31/24 - -11.15 Net Margin 06/30/25 - - 03/31/25 - -12.48 12/31/24 - -11.15 Pre-Tax Margin 06/30/25 - - 03/31/25 - -12.71 12/31/24 - -11.44 Book Value 06/30/25 - - 03/31/25 - 4.13 12/31/24 - 4.45 Inventory Turnover 06/30/25 - - 03/31/25 - 2.59 12/31/24 - 2.40 Debt-to-Equity 06/30/25 - - 03/31/25 - 1.18 12/31/24 - 0.79 Debt-to-Capital 06/30/25 - - 03/31/25 - 54.21 12/31/24 - 44.09

Powered by Zacks Investment Research ©